Gastroenterology Submission Guide: What Editors Screen Before Review

Week 1: Submission intake and editorial screen

The Gastroenterology Editorial Manager system verifies CONSORT/STROBE/PRISMA reporting-checklist completion, ethics statements, and trial registration ID. The handling AGA Associate Editor then reads the cover letter and abstract to assess GI clinical importance and translational depth. About 70 to 75 percent of submissions are desk-rejected at this stage.

Week 2: Editorial discussion + AGA family routing

Borderline papers are discussed across the Gastroenterology editorial team. Some receive transfer offers to Clinical Gastroenterology and Hepatology, Cellular and Molecular Gastroenterology and Hepatology, or Techniques and Innovations in Gastrointestinal Endoscopy where reviewer reports can carry forward.

Weeks 3 to 4: Reviewer recruitment

For papers passing the editorial screen, 2 to 3 reviewers are recruited covering GI clinical context, methods rigor, and translational framing.

Weeks 5 to 8: External peer review

Reviewers evaluate GI/liver significance, mechanism-clinical translation, methods rigor, and AGA-readership relevance.

Weeks 8 to 10: Reviewer-report synthesis and decision

Handling editor integrates reports. Major-revision decisions specify the evidence gaps that must close before resubmission.

Editorial desk-screen calibration for Gastroenterology specifically. The journal's published 3-week median first-decision target and 3-7-day internal-rejection turnaround (per AGA reporting) compress the desk-screen window dramatically relative to other AGA journals. Submissions are eligible for fast-track consideration only as original research; reviews and letters do not qualify. The journal enforces a 300-word abstract limit and 5,000-word main-text cap at desk-screen; mechanistic GI papers without explicit clinical-translation pathway are desk-rejected within 10 days regardless of mechanistic depth. The AGA appeals policy strongly discourages appeals; an appeal is appropriate only when editors misunderstood the submission or when there is evidence of unethical conduct in the peer-review process. Verify the current Editor-in-Chief and handling-editor roster on the journal's editorial-team page before quoting names in the cover letter. Our reading of current AGA author guidelines (accessed 2026-05-21) and Manusights guide-build research notes informs the patterns flagged in this guide.

The core submission question is not "how do I use Editorial Manager?" The guide for authors handles that. The real decision is whether the manuscript deserves a top-tier GI editorial read in the first place.

That matters because Gastroenterology attracts multiple kinds of papers:

• major clinical studies with direct practice implications
• translational work that bridges mechanism and human disease
• mechanistic GI science with a strong disease-facing consequence

What does not travel as well is work that is only solid within one local context. A careful single-center observational study, a narrow biomarker paper, or a mechanistic model with weak human validation may still be publishable, but often not here.

If you are unsure whether the problem is journal fit or manuscript readiness, use the free manuscript readiness check before you commit the paper to this queue.

The key point is that operational compliance is necessary but not sufficient. A perfect upload will not rescue a paper that reads more naturally as Clinical Gastroenterology and Hepatology, Hepatology, or a specialty disease journal.

The official guide is unusually explicit about what happens after upload. Use these details to audit the package before submission:

The single-center study with respectable results but limited field consequence. Editors often see this as useful work without enough reach. The more the paper depends on one institution, one workflow, or one local population, the harder it is to justify the flagship placement.

Mechanistic GI work without a convincing human tier. A model system can be elegant and still feel incomplete if the manuscript wants to make a disease-facing argument without human validation, patient-derived material, or a serious translational bridge.

A biomarker or observational paper that documents association but does not change management logic. The study may be statistically careful, but if the result does not alter diagnosis, prognosis, treatment selection, or disease understanding in a meaningful way, the flagship case weakens fast.

A package split between clinical importance and basic-science storytelling. This happens when the title and abstract promise practice-level relevance, while the body behaves like an early mechanistic paper. Editors usually detect that split before review.

A paper that is strongest only in comparison with weaker nearby journals. Flagship editors do not care that the manuscript is stronger than average work elsewhere. They care whether it is strong enough for this queue.

This page handles the public submission rules; the draft still needs a journal-specific fit check. The review tells you whether YOUR paper passes the Gastroenterology fit screen before upload, especially around editors actually screen for whether the study changes what the field would do next, human relevance is where many translational GI papers quietly weaken, and single-center scale is one of the most common hidden reasons a paper feels too local. Paid Manusights reviews include a 60-day money-back guarantee, and we do not train models on submitted manuscripts.

Editors actually screen for whether the study changes what the field would do next

In our pre-submission review work on GI and liver manuscripts, we repeatedly see that editors actually screen for whether the study changes what the field would do next. That can mean practice, trial design, disease classification, or mechanistic interpretation. If the paper does not move one of those decisions, it often feels sub-flagship even when the execution is careful.

Human relevance is where many translational GI papers quietly weaken

We also see that human relevance is where many translational GI papers quietly weaken. The mechanism may be strong in organoids, mice, or cell systems, but the human evidence still looks decorative rather than essential. That makes the translational bridge feel rhetorical instead of structural.

Check whether your Gastroenterology manuscript passes the human relevance is where many translational gi papers quietly weaken screen →

Single-center scale is one of the most common hidden reasons a paper feels too local

In our review work, single-center scale is one of the most common hidden reasons a paper feels too local. Authors often focus on p values and effect sizes, while editors are asking whether the GI community would treat the result as generalizable enough to matter broadly.

Check whether your Gastroenterology manuscript passes the single-center scale is one of the most common hidden reasons a paper feels too l screen →

We have found

Our analysis of manuscripts targeting Gastroenterology also shows a recurring packaging issue: authors often lead with disease burden or unmet need, but the editor is still looking for the sharper sentence that explains what changes in GI thinking because of this dataset. We have found that papers move up fast when the title, structured abstract, and first display item all make the same claim about clinical consequence or translational meaning. When those elements point in different directions, even strong studies look less flagship-ready.

Check whether your Gastroenterology manuscript passes the we have found screen →

The simplest test is whether you can answer all three questions cleanly:

1. What changes for GI or liver readers because of this study?
2. Why would a strong competing journal not be the more natural home?
3. Is the clinical or translational implication visible before the editor reaches the methods?

If those answers are vague, the paper is usually not yet ready for the flagship attempt.

In our pre-submission review work on Gastroenterology-targeted manuscripts, three patterns consistently predict desk-screen failure at Gastroenterology. The patterns below are the same ones the journal's handling editors and outside reviewers flag at first-pass triage.

Scope-fit ambiguity in the abstract. Gastroenterology editors move fastest on manuscripts whose contribution is obviously aligned with gastroenterology research with clinical-relevance implications for practicing gastroenterologists. The named failure pattern: mechanistic papers without clinical-translation pathway get desk-rejected within 10 days. Check whether your abstract reads to Gastroenterology's scope

Methods package incomplete for the journal's reviewer pool. Gastroenterology reviewers expect specific methodological detail. Clinical papers missing explicit endpoint pre-specification extend revision. Check if your methods package is reviewer-complete

Reference-list and clean-citation failure mode. Editorial team at Gastroenterology screens reference lists for retracted-paper inclusion. Check whether your reference list is clean against Crossref + Retraction Watch

Guide-build evidence signal for Gastroenterology. Our review of public author guidance, recent published article packages, and Manusights pre-submission review patterns points to this practical risk: Gastroenterology editors enforce clinical-relevance threshold; mechanistic papers without clinical-translation pathway get desk-rejected within 10 days. Treat this as a fit-and-artifact screen rather than a private outcome claim; official journal pages remain authoritative for submission mechanics and policy requirements.